Abstract
Adenosine triphosphate (ATP)-sensitive K+ (KATP) channels were discovered in the heart almost 30 years ago. They are present in multiple tissues and link membrane excitability to the metabolic state of the cell. Under physiological conditions, cardiac KATP channels are predominantly closed, but they may open during exertion, stress, and ischemia. Experimental and modeling studies have shown that activation of sarcolemmal KATP channels causes dramatic action potential shortening in vitro, which can be cardioprotective. Conversely, there is emerging evidence that KATP channel mutations are linked to heart diseases, including congestive heart failure and arrhythmias. The debate regarding the role, and even the very existence, of mitochondrial KATP channels is still ongoing. Filling these knowledge gaps will require further study, and integration of results from basic cellular electrophysiology, to animal models and clinical disease. This chapter will address the current understanding of cardiac KATP channels regarding molecular composition, regulation of channel activity, and physiological and pathophysiological roles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zingman LV, Zhu Z, Sierra A, Stepniak E, Burnett CM, Maksymov G, et al. Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation. J Mol Cell Cardiol. 2011;51(1):72–81.
Kane GC, Behfar A, Yamada S, Perez-Terzic C, O’Cochlain F, Reyes S, et al. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004;53 Suppl 3:S169–75.
Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, et al. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002;99(20):13278–83.
Flagg TP, Enkvetchakul D, Koster JC, Nichols CG. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev. 2010;90(3):799–829.
Reyes S, Park S, Johnson BD, Terzic A, Olson TM. KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response. Hum Genet. 2009;126(6):779–89.
Haissaguerre M, Chatel S, Sacher F, Weerasooriya R, Probst V, Loussouarn G, et al. Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol. 2009;20(1):93–8.
Medeiros-Domingo A, Tan BH, Crotti L, Tester DJ, Eckhardt L, Cuoretti A, et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm. 2010;7(10):1466–71.
Barajas-Martinez H, Hu D, Ferrer T, Onetti CG, Wu Y, Burashnikov E, et al. Molecular Genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm. 2012;9(4):548–55.
Kane GC, Liu XK, Yamada S, Olson TM, Terzic A. Cardiac KATP channels in health and disease. J Mol Cell Cardiol. 2005;38(6):937–43.
Baczko I, Husti Z, Lang V, Lepran I, Light PE. Sarcolemmal KATP channel modulators and cardiac arrhythmias. Curr Med Chem. 2011;18(24):3640–61.
Zhang H, Flagg TP, Nichols CG. Cardiac sarcolemmal K(ATP) channels: latest twists in a questing tale! J Mol Cell Cardiol. 2010;48(1):71–5.
Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 1991;261(6 Pt 2):H1675–86.
Terzic A, Jahangir A, Kurachi Y. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Am J Physiol. 1995;269(3 Pt 1):C525–45.
Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature. 2006;440(7083):470–6.
Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270(5239):1166–70.
Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Horie M, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem. 1995;270(11):5691–4.
Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd 3rd AE, Gonzalez G, et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268(5209):423–6.
Chutkow WA, Makielski JC, Nelson DJ, Burant CF, Fan Z. Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J Biol Chem. 1999;274(19):13656–65.
Shi NQ, Ye B, Makielski JC. Function and distribution of the SUR isoforms and splice variants. J Mol Cell Cardiol. 2005;39(1):51–60.
Inagaki N, Inazawa J, Seino S. cDNA sequence, gene structure, and chromosomal localization of the human ATP-sensitive potassium channel, uKATP-1, gene (KCNJ8). Genomics. 1995;30(1):102–4.
Chutkow WA, Simon MC, Le Beau MM, Burant CF. Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes. 1996;45(10):1439–45.
Clement JP, Kunjilwar K, Gonzalez G, Schwanstecher M, Panten U, Aguilar-Bryan L, et al. Association and stoichiometry of K(ATP) channel subunits. Neuron. 1997;18(5):827–38.
Shyng S, Nichols CG. Octameric stoichiometry of the KATP channel complex. J Gen Physiol. 1997;110(6):655–64.
Heginbotham L, Lu Z, Abramson T, MacKinnon R. Mutations in the K+ channel signature sequence. Biophys J. 1994;66(4):1061–7.
Schwappach B, Zerangue N, Jan YN, Jan LY. Molecular basis for K(ATP) assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter. Neuron. 2000;26(1):155–67.
Babenko AP, Bryan J. Sur domains that associate with and gate KATP pores define a novel gatekeeper. J Biol Chem. 2003;278(43):41577–80.
Chan KW, Zhang H, Logothetis DE. N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J. 2003;22(15):3833–43.
Mikhailov MV, Campbell JD, de Wet H, Shimomura K, Zadek B, Collins RF, et al. 3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1. EMBO J. 2005;24(23):4166–75.
Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, et al. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron. 1996;16(5):1011–7.
Yamada M, Isomoto S, Matsumoto S, Kondo C, Shindo T, Horio Y, et al. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J Physiol. 1997;499(Pt 3):715–20.
Kondo C, Repunte VP, Satoh E, Yamada M, Horio Y, Matsuzawa Y, et al. Chimeras of Kir6.1 and Kir6.2 reveal structural elements involved in spontaneous opening and unitary conductance of the ATP-sensitive K+ channels. Receptors Channels. 1998;6(2):129–40.
Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res. 1998;83(11):1132–43.
Lorenz E, Terzic A. Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol. 1999;31(2):425–34.
Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, et al. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001;88(6):570–7.
Chutkow WA, Samuel V, Hansen PA, Pu J, Valdivia CR, Makielski JC, et al. Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci U S A. 2001;98(20):11760–4.
Pu J, Wada T, Valdivia C, Chutkow WA, Burant CF, Makielski JC. Evidence of KATP channels in native cardiac cells without SUR. Biophys J. 2001;80:625a–6.
Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002;8(5):466–72.
Flagg TP, Kurata HT, Masia R, Caputa G, Magnuson MA, Lefer DJ, et al. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1. Circ Res. 2008;103(12):1458–65.
Singh H, Hudman D, Lawrence CL, Rainbow RD, Lodwick D, Norman RI. Distribution of Kir6.0 and SUR2 ATP-sensitive potassium channel subunits in isolated ventricular myocytes. J Mol Cell Cardiol. 2003;35(5):445–59.
van Bever L, Poitry S, Faure C, Norman RI, Roatti A, Baertschi AJ. Pore loop-mutated rat KIR6.1 and KIR6.2 suppress KATP current in rat cardiomyocytes. Am J Physiol Heart Circ Physiol. 2004;287(2):H850–9.
Morrissey A, Rosner E, Lanning J, Parachuru L, Dhar Chowdhury P, Han S, et al. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol. 2005;5(1):1.
Kono Y, Horie M, Takano M, Otani H, Xie LH, Akao M, et al. The properties of the Kir6.1-6.2 tandem channel co-expressed with SUR2A. Pflugers Arch. 2000;440(5):692–8.
Cui Y, Giblin JP, Clapp LH, Tinker A. A mechanism for ATP-sensitive potassium channel diversity: functional coassembly of two pore-forming subunits. Proc Natl Acad Sci U S A. 2001;98(2):729–34.
Chan KW, Wheeler A, Csanady L. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition. J Gen Physiol. 2008;131(1):43–58.
Cheng WW, Tong A, Flagg TP, Nichols CG. Random assembly of SUR subunits in K(ATP) channel complexes. Channels (Austin). 2008;2(1):34–8.
Wheeler A, Wang C, Yang K, Fang K, Davis K, Styer AM, et al. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels. Mol Pharmacol. 2008;74(5):1333–44.
Seharaseyon J, Sasaki N, Ohler A, Sato T, Fraser H, Johns DC, et al. Evidence against functional heteromultimerization of the KATP channel subunits Kir6.1 and Kir6.2. J Biol Chem. 2000;275(23):17561–5.
Glukhov AV, Flagg TP, Fedorov VV, Efimov IR, Nichols CG. Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol. 2010;48(1):152–60.
Masia R, Enkvetchakul D, Nichols CG. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A. J Mol Cell Cardiol. 2005;39(3):491–501.
Liu Y, Ren G, O’Rourke B, Marban E, Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol. 2001;59(2):225–30.
Ashcroft FM, Gribble FM. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels. J Diabetes Complications. 2000;14(4):192–6.
Han X, Light PE, Giles WR, French RJ. Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells. J Physiol. 1996;490(Pt 2):337–50.
Kakei M, Noma A. Adenosine-5’-triphosphate-sensitive single potassium channel in the atrioventricular node cell of the rabbit heart. J Physiol. 1984;352:265–84.
Light PE, Cordeiro JM, French RJ. Identification and properties of ATP-sensitive potassium channels in myocytes from rabbit Purkinje fibres. Cardiovasc Res. 1999;44(2):356–69.
Bao L, Kefalogianni E, Lader J, Hong M, Morley G, Fishman GI, et al. Unique properties of the ATP-sensitive K+ channel in the mouse ventricular cardiac conduction system. Circulation. 2011;4(6):926–35.
Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol. 2005;562(Pt 1):223–34.
Fukuzaki K, Sato T, Miki T, Seino S, Nakaya H. Role of sarcolemmal ATP-sensitive K+ channels in the regulation of sinoatrial node automaticity: an evaluation using Kir6.2-deficient mice. J Physiol. 2008;586(Pt 11):2767–78.
Fedorov VV, Glukhov AV, Ambrosi CM, Kostecki G, Chang R, Janks D, et al. Effects of K(ATP) channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol. 2011;51(2):215–25.
Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983;305(5930):147–8.
Lederer WJ, Nichols CG. Nucleotide modulation of the activity of rat heart ATP-sensitive K+ channels in isolated membrane patches. J Physiol. 1989;419:193–211.
Nichols CG, Lederer WJ. The regulation of ATP-sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. J Physiol. 1990;423:91–110.
Findlay I, Faivre JF. ATP-sensitive K channels in heart muscle. Spare channels. FEBS Lett. 1991;279(1):95–7.
Terzic A, Tung RT, Kurachi Y. Nucleotide regulation of ATP sensitive potassium channels. Cardiovasc Res. 1994;28(6):746–53.
Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature. 1997;387(6629):179–83.
Satoh E, Yamada M, Kondo C, Repunte VP, Horio Y, Iijima T, et al. Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil. J Physiol. 1998;511(Pt 3):663–74.
Schwanstecher M, Sieverding C, Dorschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, et al. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J. 1998;17(19):5529–35.
Zerangue N, Schwappach B, Jan YN, Jan LY. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron. 1999;22(3):537–48.
Enkvetchakul D, Nichols CG. Gating mechanism of KATP channels: function fits form. J Gen Physiol. 2003;122(5):471–80.
John SA, Weiss JN, Xie LH, Ribalet B. Molecular mechanism for ATP-dependent closure of the K+ channel Kir6.2. J Physiol. 2003;552(Pt 1):23–34.
Ribalet B, John SA, Weiss JN. Molecular basis for Kir6.2 channel inhibition by adenine nucleotides. Biophys J. 2003;84(1):266–76.
Trapp S, Haider S, Jones P, Sansom MS, Ashcroft FM. Identification of residues contributing to the ATP binding site of Kir6.2. EMBO J. 2003;22(12):2903–12.
Antcliff JF, Haider S, Proks P, Sansom MS, Ashcroft FM. Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J. 2005;24(2):229–39.
Findlay I. ATP4- and ATP.Mg inhibit the ATP-sensitive K+ channel of rat ventricular myocytes. Pflugers Arch. 1988;412(1–2):37–41.
Jovanovic A, Jovanovic S, Mays DC, Lipsky JJ, Terzic A. Diadenosine 5’,5”-P1, P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett. 1998;423(3):314–8.
Koster JC, Sha Q, Nichols CG. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol. 1999;114(2):203–13.
Nichols CG, Lederer WJ. The mechanism of KATP channel inhibition by ATP. J Gen Physiol. 1991;97(5):1095–8.
Ashcroft FM. Adenosine 5’-triphosphate-sensitive potassium channels. Annu Rev Neurosci. 1988;11:97–118.
Dunne MJ, Petersen OH. Intracellular ADP activates K+ channels that are inhibited by ATP in an insulin-secreting cell line. FEBS Lett. 1986;208(1):59–62.
Kakei M, Kelly RP, Ashcroft SJ, Ashcroft FM. The ATP-sensitivity of K+ channels in rat pancreatic B-cells is modulated by ADP. FEBS Lett. 1986;208(1):63–6.
Findlay I. Effects of ADP upon the ATP-sensitive K+ channel in rat ventricular myocytes. J Membr Biol. 1988;101(1):83–92.
Hopkins WF, Fatherazi S, Peter-Riesch B, Corkey BE, Cook DL. Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic beta-cells and HIT cells. J Membr Biol. 1992;129(3):287–95.
Shyng S, Ferrigni T, Nichols CG. Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol. 1997;110(6):643–54.
Moreau C, Jacquet H, Prost AL, D’Hahan N, Vivaudou M. The molecular basis of the specificity of action of K(ATP) channel openers. EMBO J. 2000;19(24):6644–51.
John SA, Weiss JN, Ribalet B. Regulation of cloned ATP-sensitive K channels by adenine nucleotides and sulfonylureas: interactions between SUR1 and positively charged domains on Kir6.2. J Gen Physiol. 2001;118(4):391–405.
Matsushita K, Kinoshita K, Matsuoka T, Fujita A, Fujikado T, Tano Y, et al. Intramolecular interaction of SUR2 subtypes for intracellular ADP-induced differential control of K(ATP) channels. Circ Res. 2002;90(5):554–61.
Campbell JD, Sansom MS, Ashcroft FM. Potassium channel regulation. EMBO Rep. 2003;4(11):1038–42.
Gribble FM, Tucker SJ, Haug T, Ashcroft FM. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A. 1998;95(12):7185–90.
D’Hahan N, Jacquet H, Moreau C, Catty P, Vivaudou M. A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers. Mol Pharmacol. 1999;56(2):308–15.
Gribble FM, Tucker SJ, Ashcroft FM. The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J. 1997;16(6):1145–52.
Matsuo M, Trapp S, Tanizawa Y, Kioka N, Amachi T, Oka Y, et al. Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem. 2000;275(52):41184–91.
Matsuo M, Tanabe K, Kioka N, Amachi T, Ueda K. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B. J Biol Chem. 2000;275(37):28757–63.
Matsuoka T, Matsushita K, Katayama Y, Fujita A, Inageda K, Tanemoto M, et al. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels. Circ Res. 2000;87(10):873–80.
Ueda K, Inagaki N, Seino S. MgADP antagonism to Mg2+−independent ATP binding of the sulfonylurea receptor SUR1. J Biol Chem. 1997;272(37):22983–6.
Babenko AP, Gonzalez G, Bryan J. Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers. J Biol Chem. 2000;275(2):717–20.
Bryan J, Aguilar-Bryan L. Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta. 1999;1461(2):285–303.
Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol. 1999;61:337–62.
Bienengraeber M, Alekseev AE, Abraham MR, Carrasco AJ, Moreau C, Vivaudou M, et al. ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex. FASEB J. 2000;14(13):1943–52.
Matsuo M, Kioka N, Amachi T, Ueda K. ATP binding properties of the nucleotide-binding folds of SUR1. J Biol Chem. 1999;274(52):37479–82.
Ashcroft FM, Gribble FM. Correlating structure and function in ATP-sensitive K+ channels. Trends Neurosci. 1998;21(7):288–94.
Ueda K, Komine J, Matsuo M, Seino S, Amachi T. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide. Proc Natl Acad Sci U S A. 1999;96(4):1268–72.
Masia R, Nichols CG. Functional clustering of mutations in the dimer interface of the nucleotide binding folds of the sulfonylurea receptor. J Biol Chem. 2008;283(44):30322–9.
Fan Z, Makielski JC. Anionic phospholipids activate ATP-sensitive potassium channels. J Biol Chem. 1997;272(9):5388–95.
Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker SJ, et al. PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science. 1998;282(5391):1141–4.
Shyng SL, Nichols CG. Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science. 1998;282(5391):1138–41.
Ribalet B, John SA, Xie LH, Weiss JN. Regulation of the ATP-sensitive K channel Kir6.2 by ATP and PIP(2). J Mol Cell Cardiol. 2005;39(1):71–7.
Xie LH, John SA, Ribalet B, Weiss JN. Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity. J Physiol. 2008;586(7):1833–48.
Fan Z, Makielski JC. Phosphoinositides decrease ATP sensitivity of the cardiac ATP-sensitive K(+) channel. A molecular probe for the mechanism of ATP-sensitive inhibition. J Gen Physiol. 1999;114(2):251–69.
MacGregor GG, Dong K, Vanoye CG, Tang L, Giebisch G, Hebert SC. Nucleotides and phospholipids compete for binding to the C terminus of KATP channels. Proc Natl Acad Sci U S A. 2002;99(5):2726–31.
Haider S, Tarasov AI, Craig TJ, Sansom MS, Ashcroft FM. Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis. EMBO J. 2007;26(16):3749–59.
Loussouarn G, Pike LJ, Ashcroft FM, Makhina EN, Nichols CG. Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. J Biol Chem. 2001;276(31):29098–103.
Hansen SB, Tao X, MacKinnon R. Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature. 2011;477(7365):495–8.
Shyng SL, Cukras CA, Harwood J, Nichols CG. Structural determinants of PIP(2) regulation of inward rectifier K(ATP) channels. J Gen Physiol. 2000;116(5):599–608.
Cukras CA, Jeliazkova I, Nichols CG. Structural and functional determinants of conserved lipid interaction domains of inward rectifying Kir6.2 channels. J Gen Physiol. 2002;119(6):581–91.
Cukras CA, Jeliazkova I, Nichols CG. The role of NH2-terminal positive charges in the activity of inward rectifier KATP channels. J Gen Physiol. 2002;120(3):437–46.
Larsson O, Deeney JT, Branstrom R, Berggren PO, Corkey BE. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. J Biol Chem. 1996;271(18):10623–6.
Branstrom R, Corkey BE, Berggren PO, Larsson O. Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic beta cells. J Biol Chem. 1997;272(28):17390–4.
Branstrom R, Leibiger IB, Leibiger B, Corkey BE, Berggren PO, Larsson O. Long chain coenzyme A esters activate the pore-forming subunit (Kir6.2) of the ATP-regulated potassium channel. J Biol Chem. 1998;273(47):31395–400.
Gribble FM, Proks P, Corkey BE, Ashcroft FM. Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA. J Biol Chem. 1998;273(41):26383–7.
Liu GX, Hanley PJ, Ray J, Daut J. Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart. Circ Res. 2001;88(9):918–24.
Schulze D, Rapedius M, Krauter T, Baukrowitz T. Long-chain acyl-CoA esters and phosphatidylinositol phosphates modulate ATP inhibition of KATP channels by the same mechanism. J Physiol. 2003;552(Pt 2):357–67.
Branstrom R, Aspinwall CA, Valimaki S, Ostensson CG, Tibell A, Eckhard M, et al. Long-chain CoA esters activate human pancreatic beta-cell KATP channels: potential role in type 2 diabetes. Diabetologia. 2004;47(2):277–83.
Manning Fox JE, Nichols CG, Light PE. Activation of adenosine triphosphate-sensitive potassium channels by acyl coenzyme A esters involves multiple phosphatidylinositol 4,5-bisphosphate-interacting residues. Mol Endocrinol. 2004;18(3):679–86.
Branstrom R, Leibiger IB, Leibiger B, Klement G, Nilsson J, Arhem P, et al. Single residue (K332A) substitution in Kir6.2 abolishes the stimulatory effect of long-chain acyl-CoA esters: indications for a long-chain acyl-CoA ester binding motif. Diabetologia. 2007;50(8):1670–7.
Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O’Cochlain F, Gao F, et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet. 2004;36(4):382–7.
Weiss JN, Lamp ST. Glycolysis preferentially inhibits ATP-sensitive K+ channels in isolated guinea pig cardiac myocytes. Science. 1987;238(4823):67–9.
Weiss JN, Venkatesh N. Metabolic regulation of cardiac ATP-sensitive K+ channels. Cardiovasc Drugs Ther. 1993;7 Suppl 3:499–505.
Hong M, Kefaloyianni E, Bao L, Malester B, Delaroche D, Neubert TA, et al. Cardiac ATP-sensitive K+ channel associates with the glycolytic enzyme complex. FASEB J. 2011;25(7):2456–67.
Weiss JN, Lamp ST. Cardiac ATP-sensitive K+ channels. Evidence for preferential regulation by glycolysis. J Gen Physiol. 1989;94(5):911–35.
Dzeja PP, Terzic A. Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels. FASEB J. 1998;12(7):523–9.
Alekseev AE, Hodgson DM, Karger AB, Park S, Zingman LV, Terzic A. ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol. 2005;38(6):895–905.
Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J. 1999;18(17):4722–32.
Lin YF, Jan YN, Jan LY. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J. 2000;19(5):942–55.
Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci U S A. 2000;97(16):9058–63.
Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci U S A. 2001;98(13):7623–8.
Crawford RM, Ranki HJ, Botting CH, Budas GR, Jovanovic A. Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo. FASEB J. 2002;16(1):102–4.
Jovanovic S, Jovanovic A. High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K+ channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism. Diabetes. 2005;54(2):383–93.
Dhar-Chowdhury P, Harrell MD, Han SY, Jankowska D, Parachuru L, Morrissey A, et al. The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the K(ATP) channel macromolecular complex and regulate its function. J Biol Chem. 2005;280(46):38464–70.
Thierfelder S, Doepner B, Gebhardt C, Hirche H, Benndorf K. ATP-sensitive K+ channels in heart muscle cells first open and subsequently close at maintained anoxia. FEBS Lett. 1994;351(3):365–9.
Jaburek M, Yarov-Yarovoy V, Paucek P, Garlid KD. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem. 1998;273(22):13578–82.
Rainbow RD, Norman RI, Hudman D, Davies NW, Standen NB. Reduced effectiveness of HMAR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress. J Mol Cell Cardiol. 2005;39(4):637–46.
Zhang HX, Akrouh A, Kurata HT, Remedi MS, Lawton JS, Nichols CG. HMAR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels. J Mol Cell Cardiol. 2011;50(3):552–60.
Ripoll C, Lederer WJ, Nichols CG. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356. J Pharmacol Exp Ther. 1990;255(2):429–35.
Nichols CG, Ripoll C, Lederer WJ. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res. 1991;68(1):280–7.
Weiss JN, Venkatesh N, Lamp ST. ATP-sensitive K+ channels and cellular K+ loss in hypoxic and ischaemic mammalian ventricle. J Physiol. 1992;447:649–73.
Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration. Cardiovasc Res. 1997;35(2):256–72.
Lederer WJ, Nichols CG, Smith GL. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol. 1989;413:329–49.
McPherson CD, Pierce GN, Cole WC. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. Am J Physiol. 1993;265(5 Pt 2):H1809–18.
Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur J Pharmacol. 1990;191(1):11–8.
Grover GJ, Sleph PG, Dzwonczyk S. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol. 1990;16(6):853–64.
Grover GJ, Garlid KD. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol. 2000;32(4):677–95.
Yao Z, Cavero I, Gross GJ. Activation of cardiac KATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol. 1993;264(2 Pt 2):H495–504.
Bernardo NL, D’Angelo M, Okubo S, Joy A, Kukreja RC. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart. Am J Physiol. 1999;276(4 Pt 2):H1323–30.
Lascano EC, Negroni JA, del Valle HF. Ischemic shortening of action potential duration as a result of KATP channel opening attenuates myocardial stunning by reducing calcium influx. Mol Cell Biochem. 2002;236(1–2):53–61.
Du Q, Jovanovic S, Clelland A, Sukhodub A, Budas G, Phelan K, et al. Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia. FASEB J. 2006;20(8):1131–41.
Rainbow RD, Lodwick D, Hudman D, Davies NW, Norman RI, Standen NB. SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes. J Physiol. 2004;557(Pt 3):785–94.
Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002;109(4):509–16.
Hu X, Xu X, Huang Y, Fassett J, Flagg TP, Zhang Y, et al. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload. Circ Res. 2008;103(9):1009–17.
Stoller D, Kakkar R, Smelley M, Chalupsky K, Earley JU, Shi NQ, et al. Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress. J Mol Cell Cardiol. 2007;43(4):445–54.
Elrod JW, Harrell M, Flagg TP, Gundewar S, Magnuson MA, Nichols CG, et al. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Circulation. 2008;117(11):1405–13.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36.
Gross GJ, Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol. 2003;285(3):H921–30.
Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70(2):223–33.
Rajashree R, Koster JC, Markova KP, Nichols CG, Hofmann PA. Contractility and ischemic response of hearts from transgenic mice with altered sarcolemmal K(ATP) channels. Am J Physiol Heart Circ Physiol. 2002;283(2):H584–90.
Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352(6332):244–7.
Yao Z, Gross GJ. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 1994;89(4):1769–75.
Grover GJ, D’Alonzo AJ, Parham CS, Darbenzio RB. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 1995;26(1):145–52.
Hamada K, Yamazaki J, Nagao T. Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a KATP channel opener. J Mol Cell Cardiol. 1998;30(7):1369–79.
Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D’Alonzo AJ, et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res. 1997;81(6):1072–82.
Baines CP, Liu GS, Birincioglu M, Critz SD, Cohen MV, Downey JM. Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol. 1999;276(4 Pt 2):H1361–8.
Ghosh S, Standen NB, Galinanes M. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res. 2000;45(4):934–40.
McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res. 1991;69(4):949–58.
Munch-Ellingsen J, Lokebo JE, Bugge E, Jonassen AK, Ravingerova T, Ytrehus K. 5-HD abolishes ischemic preconditioning independently of monophasic action potential duration in the heart. Basic Res Cardiol. 2000;95(3):228–34.
Rajesh KG, Sasaguri S, Suzuki R, Xing Y, Maeda H. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. Int J Cardiol. 2004;96(1):41–9.
D’Hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, et al. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A. 1999;96(21):12162–7.
Flagg TP, Remedi MS, Masia R, Gomes J, McLerie M, Lopatin AN, et al. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). J Mol Cell Cardiol. 2005;39(4):647–56.
Moritani K, Miyazaki T, Miyoshi S, Asanagi M, Zhao LS, Mitamura H, et al. Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia. Cardiovasc Drugs Ther. 1994;8(5):749–56.
Hanley PJ, Mickel M, Loffler M, Brandt U, Daut J. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542(Pt 3):735–41.
Hu H, Sato T, Seharaseyon J, Liu Y, Johns DC, O’Rourke B, et al. Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels. Mol Pharmacol. 1999;55(6):1000–5.
Suzuki M, Saito T, Sato T, Tamagawa M, Miki T, Seino S, et al. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation. 2003;107(5):682–5.
Koster JC, Knopp A, Flagg TP, Markova KP, Sha Q, Enkvetchakul D, et al. Tolerance for ATP-insensitive K(ATP) channels in transgenic mice. Circ Res. 2001;89(11):1022–9.
Foster DB, Rucker JJ, Marban E. Is Kir6.1 a subunit of mitoK(ATP)? Biochem Biophys Res Commun. 2008;366(3):649–56.
Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345(20):1473–82.
Wilde AA. ATP and the role of IK.ATP during acute myocardial ischemia: controversies revive. Cardiovasc Res. 1997;35(2):181–3.
Billman GE. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Pharmacol Ther. 2008;120(1):54–70.
Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100(15):1660–6.
Di Diego JM, Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation. 1993;88(3):1177–89.
Wolleben CD, Sanguinetti MC, Siegl PK. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol. 1989;21(8):783–8.
Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH. Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res. 1990;66(2):478–85.
Dhein S, Pejman P, Krusemann K. Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion. Eur J Pharmacol. 2000;398(2):273–84.
Shigematsu S, Sato T, Abe T, Saikawa T, Sakata T, Arita M. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation. 1995;92(8):2266–75.
Das B, Sarkar C, Karanth KS. Effects of administration of Nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(5):383–96.
Liu XK, Yamada S, Kane GC, Alekseev AE, Hodgson DM, O’Cochlain F, et al. Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia. Diabetes. 2004;53 Suppl 3:S165–8.
Flagg TP, Patton B, Masia R, Mansfield C, Lopatin AN, Yamada KA, et al. Arrhythmia susceptibility and premature death in transgenic mice overexpressing both SUR1 and Kir6.2[DeltaN30,K185Q] in the heart. Am J Physiol Heart Circ Physiol. 2007;293(1):H836–45.
Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2007;4(2):110–6.
Niho T, Notsu T, Ishikawa H, Funato H, Yamazaki M, Takahashi H, et al. Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia. Nippon Yakurigaku Zasshi. 1987;89(3):155–67.
Friedrichs GS, Abreu JN, Black SC, Chi L, Lucchesi BR. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death. Eur J Pharmacol. 1996;306(1–3):99–106.
Kita H, Miura T, Tsuchida A, Hasegawa T, Shimamoto K. Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat. J Cardiovasc Pharmacol. 1998;32(5):791–7.
Vajda S, Baczko I, Lepran I. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion. Eur J Pharmacol. 2007;577(1–3):115–23.
Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 1994;28(7):933–46.
Cameron JS, Kimura S, Jackson-Burns DA, Smith DB, Bassett AL. ATP-sensitive K+ channels are altered in hypertrophied ventricular myocytes. Am J Physiol. 1988;255(5 Pt 2):H1254–8.
Yuan F, Brandt NR, Pinto JM, Wasserlauf BJ, Myerburg RJ, Bassett AL. Hypertrophy decreases cardiac KATP channel responsiveness to exogenous and locally generated (glycolytic) ATP. J Mol Cell Cardiol. 1997;29(10):2837–48.
Shimokawa J, Yokoshiki H, Tsutsui H. Impaired activation of ATP-sensitive K+ channels in endocardial myocytes from left ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 2007;293(6):H3643–9.
Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, et al. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol. 2006;577(Pt 3):1053–65.
Kane GC, Behfar A, Dyer RB, O’Cochlain DF, Liu XK, Hodgson DM, et al. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006;15(15):2285–97.
Koumi SI, Martin RL, Sato R. Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts. Am J Physiol. 1997;272(4 Pt 2):H1656–65.
Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, et al. Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J. 2003;22(8):1732–42.
Villareal DT, Koster JC, Robertson H, Akrouh A, Miyake K, Bell GI, et al. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes. 2009;58(8):1869–78.
Reyes S, Terzic A, Mahoney DW, Redfield MM, Rodeheffer RJ, Olson TM. K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study. Hum Genet. 2008;123(6):665–7.
Tester DJ, Tan BH, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011;4(5):510–5.
Koster JC, Permutt MA, Nichols CG. Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection. Diabetes. 2005;54(11):3065–72.
Aittoniemi J, Fotinou C, Craig TJ, de Wet H, Proks P, Ashcroft FM. Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philos Trans R Soc Lond B Biol Sci. 2009;364(1514):257–67.
Ashcroft FM. K(ATP) channels and insulin secretion: a key role in health and disease. Biochem Soc Trans. 2006;34(Pt 2):243–6.
Acknowledgement.
Our own experimental work has been supported by NIH grants HL45742, HL54171 and HL95010. We are grateful to the numerous former laboratory colleagues and collaborators for their contributions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Zhang, H.X., Silva, J.R., Nichols, C.G. (2013). Cardiac KATP Channels in Health and Diseases. In: Gussak, I., Antzelevitch, C. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-4471-4881-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4881-4_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4880-7
Online ISBN: 978-1-4471-4881-4
eBook Packages: MedicineMedicine (R0)